St. Jude Medical Inc. (announced European CE mark approval of the Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The Assura family of devices, featuring Shockguard technology has three new algorithms that help protect patients against inappropriate shocks while providing the highest amount of delivered energy. These improvements are projected to reduce inappropriate therapy by 74 percent, allowing for more effective therapy. Products currently available in Europe include the Quadra Assura CRT-D, Unify Assura CRT-D and Fortify Assura ICD.

MRI 2012: Broadening Your Field of View KLS MRI Systems

The introduction of new technology into the magnetic resonance imaging (MRI) landscape has changed the face of the market segment over the last year. Although MRI satisfaction scores tend to cluster together, the differences are in the details, according to recent findings from healthcare technology research firm KLAS in its report MRI 2012: Broadening Your Field of View.
SCAI Ad Hoc PCI Stenting Cath Lab Clinical Trial

When tests reveal that a patient’s heart artery is blocked and blood flow to the heart is restricted, should the doctor fix it with a stent or stop the test and discuss treatment options with the patient? Recommendations published by the Society for Cardiovascular Angiography and Interventions (SCAI) provide new guidance on when physicians should move forward immediately to open a blocked artery versus when to stop the test for further discussion with the patient or consultation with a heart surgeon.

RamSoft announced its partnership with Digisonics to offer integrated, vendor-neutral cardiac post-processing and structured reporting for all cardiovascular modalities. Digisonics was recently named Best in KLAS for the Cardiology market segment for the fifth consecutive year.

According to Millennium Research Group (MRG), approximately 80 percent of transcatheter aortic valve replacement (TAVR) procedures are being performed on high-risk patients who are ineligible for surgical heart valve replacement. New clinical evidence that supports TAVR in treatment of intermediate and high-risk operable patients has led to expanded reimbursement for a new patient base for the procedure.

Merge Healthcare Inc. announced that Merge Hemo has been named the "Category Leader" in the "2012 Best in KLAS Awards: Software & Services" report for Cardiology Hemodynamics rankings for the second consecutive year.

Cerebral Angioplasty Stents Radiology Stroke treatment devices

Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online in the journal Radiology.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now